Fulcrum Therapeutics Inc. (FULC) Tops Q1 EPS by 5c

Fulcrum Therapeutics Inc. (NASDAQ: FULC) reported Q1 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Fulcrum Therapeutics Inc. (FULC) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• PagerDuty, Inc. (PD) Tops Q2 EPS by 1c; offers guidance
• Lifevantage (LFVN) Misses Q4 EPS by 2c